# Patient-Derived Xenografts to Reduce Cancer Health Disparities

> **NCT04410302** · — · UNKNOWN · sponsor: **University of California, Davis** · enrollment: 500 (estimated)

## Conditions studied

- Bladder Carcinoma
- Gastric Carcinoma
- Liver and Intrahepatic Bile Duct Carcinoma
- Lung Carcinoma
- Malignant Neoplasm

## Interventions

- **PROCEDURE:** Biospecimen Collection

## Key facts

- **NCT ID:** NCT04410302
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-12
- **Primary completion:** 2024-06
- **Final completion:** 2024-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2023-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04410302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04410302, "Patient-Derived Xenografts to Reduce Cancer Health Disparities". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04410302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*